You are here

  • Home
  • Archive
  • Volume 68, Issue 1
  • Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation

Article metrics

Article menu
Download PDFPDF
PostScript
Letter
Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation

 

Online download statistics by month:

Online download statistics by month: January 2018 to March 2021

AbstractFullPdf
Jan 2018834161123
Feb 20185213624
Mar 20183004116
Apr 20182173515
May 20181671411
Jun 2018119105
Jul 20182051511
Aug 20181391711
Sep 2018168106
Oct 2018124185
Nov 201815263
Dec 20183995133
Jan 20192183624
Feb 2019106178
Mar 20191201513
Apr 201986149
May 2019107147
Jun 20191021513
Jul 20199995
Aug 20198385
Sep 201994207
Oct 201979135
Nov 2019100125
Dec 201974114
Jan 20209754
Feb 20209332
Mar 202010739
Apr 20207967
May 202053119
Jun 20206453
Jul 202010456
Aug 20204132
Sep 202089411
Oct 20207644
Nov 20209353
Dec 202010155
Jan 202112116
Feb 202112127
Mar 20211251214
Total5977672460